BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34299087)

  • 1. Elevated Circulating and Placental SPINT2 Is Associated with Placental Dysfunction.
    Murphy CN; Walker SP; MacDonald TM; Keenan E; Hannan NJ; Wlodek ME; Myers J; Briffa JF; Romano T; Roddy Mitchell A; Whigham CA; Cannon P; Nguyen TV; Kandel M; Pritchard N; Tong S; Kaitu'u-Lino TJ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast.
    de Alwis N; Beard S; Binder NK; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Stock O; Groom KM; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Tong S; Hannan NJ
    Sci Rep; 2021 Oct; 11(1):20670. PubMed ID: 34667209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia.
    Mandò C; De Palma C; Stampalija T; Anelli GM; Figus M; Novielli C; Parisi F; Clementi E; Ferrazzi E; Cetin I
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E404-13. PubMed ID: 24347055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial protein C receptor is increased in preterm preeclampsia and fetal growth restriction.
    Andres F; Hannan NJ; Walker SP; MacDonald TM; Wong GP; Murphy C; Cannon P; Kandel M; Masci J; Nguyen TV; Abboud A; Idzes D; Kyritsis V; Pritchard N; Tong S; Kaitu'u-Lino TJ
    FASEB J; 2022 Dec; 36(12):e22651. PubMed ID: 36394528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental transcriptional and histologic subtypes of normotensive fetal growth restriction are comparable to preeclampsia.
    Gibbs I; Leavey K; Benton SJ; Grynspan D; Bainbridge SA; Cox BJ
    Am J Obstet Gynecol; 2019 Jan; 220(1):110.e1-110.e21. PubMed ID: 30312585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.
    Griffin M; Heazell AEP; Chappell LC; Zhao J; Lawlor DA
    Syst Rev; 2020 Apr; 9(1):78. PubMed ID: 32268905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental development and function in women with a history of placenta-related complications: a systematic review.
    Reijnders IF; Mulders AGMGJ; Koster MPH
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):248-257. PubMed ID: 29125627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study.
    Barton JR; Woelkers DA; Newman RB; Combs CA; How HY; Boggess KA; Martin JN; Kupfer K; Sibai BM;
    Am J Obstet Gynecol; 2020 Mar; 222(3):259.e1-259.e11. PubMed ID: 31518550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paternal Expressed Gene 10 (PEG10) is decreased in early-onset preeclampsia.
    Baird L; Cannon P; Kandel M; Nguyen TV; Nguyen A; Wong G; Murphy C; Brownfoot FC; Kadife E; Hannan NJ; Tong S; Bartho LA; Kaitu'u-Lino TJ
    Reprod Biol Endocrinol; 2023 Jul; 21(1):65. PubMed ID: 37464405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features.
    Salafia CM; Minior VK; Pezzullo JC; Popek EJ; Rosenkrantz TS; Vintzileos AM
    Am J Obstet Gynecol; 1995 Oct; 173(4):1049-57. PubMed ID: 7485292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast.
    de Alwis N; Beard S; Binder NK; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Stock O; Groom KM; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Tong S; Hannan NJ
    Pregnancy Hypertens; 2021 Aug; 25():255-261. PubMed ID: 34325289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2*-weighted placental magnetic resonance imaging: a biomarker of placental dysfunction in small-for-gestational-age pregnancies.
    Hansen DN; Sinding M; Petersen A; Christiansen OB; Uldbjerg N; Peters DA; Frøkjær JB; Sørensen A
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100578. PubMed ID: 35114424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
    Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
    Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics Identifies Placental Dysfunction and Confirms Flt-1 (FMS-Like Tyrosine Kinase Receptor 1) Biomarker Specificity.
    Austdal M; Silva GB; Bowe S; Thomsen LCV; Tangerås LH; Bjørge L; Bathen TF; Iversen AC
    Hypertension; 2019 Nov; 74(5):1136-1143. PubMed ID: 31495279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental glucose transporter 3 (GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction.
    Janzen C; Lei MY; Cho J; Sullivan P; Shin BC; Devaskar SU
    Placenta; 2013 Nov; 34(11):1072-8. PubMed ID: 24011442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonographic maturation of the placenta at 30 to 34 weeks is not associated with second trimester markers of placental insufficiency in low-risk pregnancies.
    Walker MG; Hindmarsh PC; Geary M; Kingdom JCP
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1134-1139. PubMed ID: 21176324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction.
    Fosheim IK; Jacobsen DP; Sugulle M; Alnaes-Katjavivi P; Fjeldstad HES; Ueland T; Lekva T; Staff AC
    Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100794. PubMed ID: 36334725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction.
    Lappas M; McCracken S; McKelvey K; Lim R; James J; Roberts CT; Fournier T; Alfaidy N; Powell KL; Borg AJ; Morris JM; Leaw B; Singh H; Ebeling PR; Wallace EM; Parry LJ; Dimitriadis E; Murthi P
    Mol Hum Reprod; 2018 Feb; 24(2):94-109. PubMed ID: 29272530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental ABCA1 and ABCG1 expression in gestational disease: Pre-eclampsia affects ABCA1 levels in syncytiotrophoblasts.
    Baumann M; Körner M; Huang X; Wenger F; Surbek D; Albrecht C
    Placenta; 2013 Nov; 34(11):1079-86. PubMed ID: 23880356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.